메뉴 건너뛰기




Volumn 48, Issue 1, 2007, Pages 1-9

Potential medical and surgical complications of serotonergic antidepressant medications

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; AMOXAPINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; DESIPRAMINE; DEXTROMETHORPHAN; DIURETIC AGENT; FLUOXETINE; FLUVOXAMINE; HYPERICUM PERFORATUM EXTRACT; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; MOOD STABILIZER; NATURAL PRODUCT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE DERIVATIVE; OXYTOCIN; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VASOPRESSIN;

EID: 33845966053     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.48.1.1     Document Type: Review
Times cited : (58)

References (97)
  • 1
    • 9744226667 scopus 로고    scopus 로고
    • Trends in prescribing of selective serotonin-reuptake inhibitors and other newer antidepressant agents in adult primary care. (Primary Care Companion)
    • Pirraglia PA, Stafford RS, Singer DE: Trends in prescribing of selective serotonin-reuptake inhibitors and other newer antidepressant agents in adult primary care. (Primary Care Companion) J Clin Psychiatry 2003; 5:153-157
    • (2003) J Clin Psychiatry , vol.5 , pp. 153-157
    • Pirraglia, P.A.1    Stafford, R.S.2    Singer, D.E.3
  • 2
    • 0036094878 scopus 로고    scopus 로고
    • Psychotropic drugs and the ECG: Focus on the QTc interval
    • Goodnick PJ, Jerry J, Parra F: Psychotropic drugs and the ECG: focus on the QTc interval. Expert Opin Pharmacother 2002; 3:479-498
    • (2002) Expert Opin Pharmacother , vol.3 , pp. 479-498
    • Goodnick, P.J.1    Jerry, J.2    Parra, F.3
  • 3
    • 1542316301 scopus 로고    scopus 로고
    • Cyclic antidepressants and the risk of sudden cardiac death
    • Ray WA, Meredith S, Thapa PB, et al: Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004; 75:234-241
    • (2004) Clin Pharmacol Ther , vol.75 , pp. 234-241
    • Ray, W.A.1    Meredith, S.2    Thapa, P.B.3
  • 4
    • 0028946692 scopus 로고
    • Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs
    • Spigset O, Hedenmalm K: Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Saf 1995; 12:209-225
    • (1995) Drug Saf , vol.12 , pp. 209-225
    • Spigset, O.1    Hedenmalm, K.2
  • 5
    • 0029843155 scopus 로고    scopus 로고
    • Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin-reuptake inhibitors: A review of spontaneous reports
    • Liu BA, Mittmann N, Knowles SR, et al: Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin-reuptake inhibitors: a review of spontaneous reports. CMAJ 1996; 155:519-527
    • (1996) CMAJ , vol.155 , pp. 519-527
    • Liu, B.A.1    Mittmann, N.2    Knowles, S.R.3
  • 7
    • 0031984133 scopus 로고    scopus 로고
    • Incidence of selective serotonin-reuptake inhibitor (SSRI)-induced hyponatraemia due to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion in the elderly
    • Bouman WP, Pinner G, Johnson H: Incidence of selective serotonin-reuptake inhibitor (SSRI)-induced hyponatraemia due to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion in the elderly. Int J Geriatr Psychiatry 1998; 13:12-15
    • (1998) Int J Geriatr Psychiatry , vol.13 , pp. 12-15
    • Bouman, W.P.1    Pinner, G.2    Johnson, H.3
  • 8
    • 10744232653 scopus 로고    scopus 로고
    • Paroxetine-induced hyponatremia in older adults: A 12-week prospective study
    • Fabian TJ, Amico JA, Kroboth PD, et al: Paroxetine-induced hyponatremia in older adults: a 12-week prospective study. Arch Intern Med 2004; 164:327-332
    • (2004) Arch Intern Med , vol.164 , pp. 327-332
    • Fabian, T.J.1    Amico, J.A.2    Kroboth, P.D.3
  • 9
    • 0035020354 scopus 로고    scopus 로고
    • Hyponatraemia and selective serotonin-reuptake inhibitors in elderly patients
    • Kirby D, Ames D: Hyponatraemia and selective serotonin-reuptake inhibitors in elderly patients. Int J Geriatr Psychiatry 2001; 16:484-493
    • (2001) Int J Geriatr Psychiatry , vol.16 , pp. 484-493
    • Kirby, D.1    Ames, D.2
  • 10
    • 0025696013 scopus 로고
    • The management of symptomatic hyponatremia
    • Sterns RH: The management of symptomatic hyponatremia. Semin Nephrol 1990; 10:503-514
    • (1990) Semin Nephrol , vol.10 , pp. 503-514
    • Sterns, R.H.1
  • 11
    • 0027212698 scopus 로고
    • Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter
    • Lesch KP, Wolozin BL, Murphy DL, et al: Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 1993; 60:2319-2322
    • (1993) J Neurochem , vol.60 , pp. 2319-2322
    • Lesch, K.P.1    Wolozin, B.L.2    Murphy, D.L.3
  • 12
    • 0033736177 scopus 로고    scopus 로고
    • Paroxetine decreases platelet serotonin storage and platelet function in human beings
    • Hergovich N, Aigner M, Eichler HG, et al: Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther 2000; 68:435-442
    • (2000) Clin Pharmacol Ther , vol.68 , pp. 435-442
    • Hergovich, N.1    Aigner, M.2    Eichler, H.G.3
  • 13
    • 0026566868 scopus 로고
    • Bleeding, a side effect of fluoxetine (letter)
    • Aranth J, Lindberg C: Bleeding, a side effect of fluoxetine (letter). Am J Psychiatry 1992; 149:412
    • (1992) Am J Psychiatry , vol.149 , pp. 412
    • Aranth, J.1    Lindberg, C.2
  • 14
    • 0030281668 scopus 로고    scopus 로고
    • Fluvoxarnine-associated bleeding
    • Leung M, Shore R: Fluvoxarnine-associated bleeding. Can J Psychiatry 1996; 41:604-605
    • (1996) Can J Psychiatry , vol.41 , pp. 604-605
    • Leung, M.1    Shore, R.2
  • 15
  • 16
    • 0030008115 scopus 로고    scopus 로고
    • Subhyaloid haemorrhage with fluoxetine
    • Wilmshurst PT, Kumar AV: Subhyaloid haemorrhage with fluoxetine. Eye 1996; 10 (Pt 1):141
    • (1996) Eye , vol.10 , Issue.PART 1 , pp. 141
    • Wilmshurst, P.T.1    Kumar, A.V.2
  • 17
    • 0032005912 scopus 로고    scopus 로고
    • Spontaneous ecchymoses due to paroxetine administration
    • Cooper TA, Valcour VG, Gibbons RB, et al: Spontaneous ecchymoses due to paroxetine administration. Am J Med 1998; 104:197-198
    • (1998) Am J Med , vol.104 , pp. 197-198
    • Cooper, T.A.1    Valcour, V.G.2    Gibbons, R.B.3
  • 18
    • 0033598594 scopus 로고    scopus 로고
    • Association between selective serotonin reuptake-inhibitors and upper gastrointestinal bleeding: Population-based, case-control study
    • de Abajo FJ, Rodriguez LA, Montero D: Association between selective serotonin reuptake-inhibitors and upper gastrointestinal bleeding: population-based, case-control study. BMJ 1999; 319(7217):1106-1109
    • (1999) BMJ , vol.319 , Issue.7217 , pp. 1106-1109
    • de Abajo, F.J.1    Rodriguez, L.A.2    Montero, D.3
  • 19
    • 13744265417 scopus 로고    scopus 로고
    • Use of selective serotonin reuptake-inhibitors and risk of upper gastrointestinal tract bleeding: A population-based cohort study
    • Dalton SO, Johansen C, Mellemkjaer L, et al: Use of selective serotonin reuptake-inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003; 163:59-64
    • (2003) Arch Intern Med , vol.163 , pp. 59-64
    • Dalton, S.O.1    Johansen, C.2    Mellemkjaer, L.3
  • 20
    • 15844407976 scopus 로고    scopus 로고
    • General population-based study of the impact of tricyclic and selective serotonin-reuptake inhibitor antidepressants on the risk of acute myocardial infarction
    • Tata LJ, West J, Smith C, et al: General population-based study of the impact of tricyclic and selective serotonin-reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart 2005; 91:465-471
    • (2005) Heart , vol.91 , pp. 465-471
    • Tata, L.J.1    West, J.2    Smith, C.3
  • 21
    • 0035934609 scopus 로고    scopus 로고
    • Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: Retrospective cohort study
    • van Walraven C, Mamdani MM, Wells PS, et al: Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 2001; 323(7314):655-658
    • (2001) BMJ , vol.323 , Issue.7314 , pp. 655-658
    • van Walraven, C.1    Mamdani, M.M.2    Wells, P.S.3
  • 22
    • 33645046396 scopus 로고    scopus 로고
    • Increased use of selective serotonin-reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: A multicentre retrospective analysis
    • Wessinger S, Kaplan M, Choi L, et al: Increased use of selective serotonin-reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 2006; 23:937-944
    • (2006) Aliment Pharmacol Ther , vol.23 , pp. 937-944
    • Wessinger, S.1    Kaplan, M.2    Choi, L.3
  • 23
    • 27944496050 scopus 로고    scopus 로고
    • Antidepressants, warfarin, and the risk of hemorrhage
    • Kurdyak PA, Juurlink DN, Kopp A, et al: Antidepressants, warfarin, and the risk of hemorrhage. J Clin Psychopharmacol 2005; 25:561-564
    • (2005) J Clin Psychopharmacol , vol.25 , pp. 561-564
    • Kurdyak, P.A.1    Juurlink, D.N.2    Kopp, A.3
  • 24
    • 8844233380 scopus 로고    scopus 로고
    • Association of risk of abnormal bleeding with degree of serotonin-reuptake inhibition by antidepressants
    • Meijer WE, Heerdink ER, Nolen WA, et al: Association of risk of abnormal bleeding with degree of serotonin-reuptake inhibition by antidepressants. Arch Intern Med 2004; 164:2367-2370
    • (2004) Arch Intern Med , vol.164 , pp. 2367-2370
    • Meijer, W.E.1    Heerdink, E.R.2    Nolen, W.A.3
  • 25
    • 0036278007 scopus 로고    scopus 로고
    • Selective serotonin-reuptake inhibitors and the risk of stroke: A population-based case-control study
    • Bak S, Tsiropoulos I, Kjaersgaard JO, et al: Selective serotonin-reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke 2002; 33:1465-1473
    • (2002) Stroke , vol.33 , pp. 1465-1473
    • Bak, S.1    Tsiropoulos, I.2    Kjaersgaard, J.O.3
  • 26
    • 0034131180 scopus 로고    scopus 로고
    • Intracranial haemorrhage and use of selective serotonin reuptake inhibitors
    • de Abajo FJ, Jick H, Derby L, et al: Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol 2000; 50:43-47
    • (2000) Br J Clin Pharmacol , vol.50 , pp. 43-47
    • de Abajo, F.J.1    Jick, H.2    Derby, L.3
  • 27
    • 0142181146 scopus 로고    scopus 로고
    • Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients
    • Movig KL, Janssen MW, de Waal-Malefijt J, et al: Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 2003; 163:2354-2358
    • (2003) Arch Intern Med , vol.163 , pp. 2354-2358
    • Movig, K.L.1    Janssen, M.W.2    de Waal-Malefijt, J.3
  • 28
    • 1342328631 scopus 로고    scopus 로고
    • A critical review of selective serotonin-reuptake inhibitor-associated bleeding: Balancing the risk of treating hepatitis C-infected patients
    • Weinrieb RM, Auriacombe M, Lynch KG, et al: A critical review of selective serotonin-reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients. J Clin Psychiatry 2003; 64:1502-1510
    • (2003) J Clin Psychiatry , vol.64 , pp. 1502-1510
    • Weinrieb, R.M.1    Auriacombe, M.2    Lynch, K.G.3
  • 30
    • 0025869797 scopus 로고
    • The serotonin syndrome
    • Sternbach H: The serotonin syndrome. Am J Psychiatry 1991; 148:705-713
    • (1991) Am J Psychiatry , vol.148 , pp. 705-713
    • Sternbach, H.1
  • 31
    • 0032720804 scopus 로고    scopus 로고
    • Antidepressants and the serotonin syndrome in general practice
    • Mackay FJ, Dunn NR, Mann RD: Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract 1999; 49(448):871-874
    • (1999) Br J Gen Pract , vol.49 , Issue.448 , pp. 871-874
    • Mackay, F.J.1    Dunn, N.R.2    Mann, R.D.3
  • 32
    • 4444284449 scopus 로고    scopus 로고
    • Relative toxicity of selective serotonin-reuptake inhibitors (SSRIs) in overdose
    • Isbister GK, Bowe SJ, Dawson A, et al: Relative toxicity of selective serotonin-reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004; 42:277-285
    • (2004) J Toxicol Clin Toxicol , vol.42 , pp. 277-285
    • Isbister, G.K.1    Bowe, S.J.2    Dawson, A.3
  • 33
    • 15044361698 scopus 로고    scopus 로고
    • The serotonin syndrome
    • Boyer EW, Shannon M: The serotonin syndrome. N Engl J Med 2005; 352:1112-1120
    • (2005) N Engl J Med , vol.352 , pp. 1112-1120
    • Boyer, E.W.1    Shannon, M.2
  • 34
    • 0141786960 scopus 로고    scopus 로고
    • Serotonin syndrome and other serotonergic disorders
    • Ener RA, Meglathery SB, Van Decker WA, et al: Serotonin syndrome and other serotonergic disorders. Pain Med 2003; 4:63-74
    • (2003) Pain Med , vol.4 , pp. 63-74
    • Ener, R.A.1    Meglathery, S.B.2    Van Decker, W.A.3
  • 35
    • 32344446421 scopus 로고    scopus 로고
    • Interaction of serotonergic antidepressants and opioid analgesics: Is serotonin syndrome going undetected?
    • Gnanadesigan N, Espinoza RT, Smith R, et al: Interaction of serotonergic antidepressants and opioid analgesics: is serotonin syndrome going undetected? J Am Med Dir Assoc 2005; 6:265-269
    • (2005) J Am Med Dir Assoc , vol.6 , pp. 265-269
    • Gnanadesigan, N.1    Espinoza, R.T.2    Smith, R.3
  • 36
    • 0029739769 scopus 로고    scopus 로고
    • Serotonin syndrome complicating migraine pharmacotherapy
    • Mathew NT, Tietjen GE, Lucker C: Serotonin syndrome complicating migraine pharmacotherapy. Cephalalgia 1996; 16:323-327
    • (1996) Cephalalgia , vol.16 , pp. 323-327
    • Mathew, N.T.1    Tietjen, G.E.2    Lucker, C.3
  • 37
    • 29244474918 scopus 로고    scopus 로고
    • A case of serotonin syndrome precipitated by abuse of the anti-cough remedy dextromethorphan in a bipolar patient treated with fluoxetine and lithium
    • Navarro A, Perry C, Bobo WV: A case of serotonin syndrome precipitated by abuse of the anti-cough remedy dextromethorphan in a bipolar patient treated with fluoxetine and lithium. Gen Hosp Psychiatry 2006; 28:78-80
    • (2006) Gen Hosp Psychiatry , vol.28 , pp. 78-80
    • Navarro, A.1    Perry, C.2    Bobo, W.V.3
  • 38
    • 0034620261 scopus 로고    scopus 로고
    • Herb-drug interactions
    • Fugh-Berman A: Herb-drug interactions. Lancet 2000; 355(9198):134-138
    • (2000) Lancet , vol.355 , Issue.9198 , pp. 134-138
    • Fugh-Berman, A.1
  • 39
    • 2642533709 scopus 로고    scopus 로고
    • Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine
    • Gahlinger PM: Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine. Am Fam Physician 2004; 69:2619-2626
    • (2004) Am Fam Physician , vol.69 , pp. 2619-2626
    • Gahlinger, P.M.1
  • 40
    • 0033796137 scopus 로고    scopus 로고
    • An exploratory approach to the serotonin syndrome: An update of clinical phenomenology and revised diagnostic criteria
    • Radomski JW, Dursun SM, Reveley MA, et al: An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses 2000; 55:218-224
    • (2000) Med Hypotheses , vol.55 , pp. 218-224
    • Radomski, J.W.1    Dursun, S.M.2    Reveley, M.A.3
  • 41
  • 42
    • 0030862983 scopus 로고    scopus 로고
    • Serotonin syndrome, a clinical update
    • Mills KC: Serotonin syndrome, a clinical update. Crit Care Clin 1997; 13:763-783
    • (1997) Crit Care Clin , vol.13 , pp. 763-783
    • Mills, K.C.1
  • 43
    • 0042377403 scopus 로고    scopus 로고
    • The Hunter Serotonin Toxicity Criteria: Simple and accurate diagnostic decision rules for serotonin toxicity
    • Dunkley EJ, Isbister GK, Sibbritt D, et al: The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96:635-642
    • (2003) QJM , vol.96 , pp. 635-642
    • Dunkley, E.J.1    Isbister, G.K.2    Sibbritt, D.3
  • 44
    • 0030055191 scopus 로고    scopus 로고
    • Toxic serotonin syndrome or neuroleptic malignant syndrome?
    • Fink M: Toxic serotonin syndrome or neuroleptic malignant syndrome? Pharmacopsychiatry 1996; 29:159-161
    • (1996) Pharmacopsychiatry , vol.29 , pp. 159-161
    • Fink, M.1
  • 45
    • 0029988896 scopus 로고    scopus 로고
    • Serotonin-dopamine interaction and its relevance to schizophrenia
    • Kapur S, Remington G: Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 1996; 153:466-476
    • (1996) Am J Psychiatry , vol.153 , pp. 466-476
    • Kapur, S.1    Remington, G.2
  • 46
    • 4344715163 scopus 로고    scopus 로고
    • Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: A randomized, double-blind, placebo-controlled discontinuation study
    • Montgomery SA, Kennedy SH, Burrows GD, et al: Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study. Int Clin Psychopharmacol 2004; 19:271-280
    • (2004) Int Clin Psychopharmacol , vol.19 , pp. 271-280
    • Montgomery, S.A.1    Kennedy, S.H.2    Burrows, G.D.3
  • 47
    • 0020041697 scopus 로고
    • Recurrence of depression after discontinuation of long-term amitriptyline treatment
    • Bialos D, Giller E, Jatlow P, et al: Recurrence of depression after discontinuation of long-term amitriptyline treatment. Am J Psychiatry 1982; 139:325-329
    • (1982) Am J Psychiatry , vol.139 , pp. 325-329
    • Bialos, D.1    Giller, E.2    Jatlow, P.3
  • 48
    • 0001137855 scopus 로고
    • Withdrawal symptoms following dicontinuation of imipramine therapy
    • Kramer JC, Klein DF, Fink M: Withdrawal symptoms following dicontinuation of imipramine therapy. Am J Psychiatry 1961; 118:549-550
    • (1961) Am J Psychiatry , vol.118 , pp. 549-550
    • Kramer, J.C.1    Klein, D.F.2    Fink, M.3
  • 49
    • 0021676596 scopus 로고
    • Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists
    • Reid JL, Campbell BC, Hamilton CA: Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists. Hypertension 1984; 6(5 Pt 2):1171-1175
    • (1984) Hypertension , vol.6 , Issue.5 PART 2 , pp. 1171-1175
    • Reid, J.L.1    Campbell, B.C.2    Hamilton, C.A.3
  • 50
    • 0018382160 scopus 로고
    • Clonidine withdrawal: Mechanism and frequency of rebound hypertension
    • Geyskes GG, Boer P, Dorhout-Mees EJ: Clonidine withdrawal: mechanism and frequency of rebound hypertension. Br J Clin Pharmacol 1979; 7:55-62
    • (1979) Br J Clin Pharmacol , vol.7 , pp. 55-62
    • Geyskes, G.G.1    Boer, P.2    Dorhout-Mees, E.J.3
  • 51
    • 0015408035 scopus 로고
    • Propranolol and polythiazide in treatment of hypertension
    • O'Brien ET, MacKinnon J: Propranolol and polythiazide in treatment of hypertension. Br Heart J 1972; 34:1042-1044
    • (1972) Br Heart J , vol.34 , pp. 1042-1044
    • O'Brien, E.T.1    MacKinnon, J.2
  • 52
    • 0036245708 scopus 로고    scopus 로고
    • Discontinuation syndrome in dysthymic patients treated with selective serotonin-reuptake inhibitors: A clinical investigation
    • Bogetto F, Bellino S, Revello RB, et al: Discontinuation syndrome in dysthymic patients treated with selective serotonin-reuptake inhibitors: a clinical investigation. CNS Drugs 2002; 16:273-283
    • (2002) CNS Drugs , vol.16 , pp. 273-283
    • Bogetto, F.1    Bellino, S.2    Revello, R.B.3
  • 53
    • 0033899154 scopus 로고    scopus 로고
    • Selective serotonin-reuptake inhibitor discontinuation syndrome: Proposed diagnostic criteria
    • Black K, Shea C, Dursun S, et al: Selective serotonin-reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci 2000; 25:255-261
    • (2000) J Psychiatry Neurosci , vol.25 , pp. 255-261
    • Black, K.1    Shea, C.2    Dursun, S.3
  • 54
    • 28444452940 scopus 로고    scopus 로고
    • Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder
    • Perahia DG, Kajdasz DK, Desaiah D, et al: Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder. J Affect Disord 2005; 89:207-212
    • (2005) J Affect Disord , vol.89 , pp. 207-212
    • Perahia, D.G.1    Kajdasz, D.K.2    Desaiah, D.3
  • 55
    • 33646799096 scopus 로고    scopus 로고
    • Prospective studies of adverse events related to antidepressant discontinuation
    • Fava M: Prospective studies of adverse events related to antidepressant discontinuation. J Clin Psychiatry 2006; 67 (suppl 4):14-21
    • (2006) J Clin Psychiatry , vol.67 , Issue.SUPPL. 4 , pp. 14-21
    • Fava, M.1
  • 56
    • 0029904001 scopus 로고    scopus 로고
    • A comparison of the post-marketing safety of four selective serotonin-reuptake inhibitors, including the investigation of symptoms occurring on withdrawal
    • Price JS, Waller PC, Wood SM, et al: A comparison of the post-marketing safety of four selective serotonin-reuptake inhibitors, including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol 1996; 42:757-763
    • (1996) Br J Clin Pharmacol , vol.42 , pp. 757-763
    • Price, J.S.1    Waller, P.C.2    Wood, S.M.3
  • 57
    • 0032527557 scopus 로고    scopus 로고
    • Selective serotonin-reuptake inhibitor discontinuation syndrome: A randomized clinical trial
    • Rosenbaum JF, Fava M, Hoog SL, et al: Selective serotonin-reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry 1998; 44:77-87
    • (1998) Biol Psychiatry , vol.44 , pp. 77-87
    • Rosenbaum, J.F.1    Fava, M.2    Hoog, S.L.3
  • 58
    • 0034167383 scopus 로고    scopus 로고
    • Interruption of selective serotonin-reuptake inhibitor treatment: Double-blind, placebo-controlled trial
    • Michelson D, Fava M, Amsterdam J, et al: Interruption of selective serotonin-reuptake inhibitor treatment: double-blind, placebo-controlled trial. Br J Psychiatry 2000; 176:363-368
    • (2000) Br J Psychiatry , vol.176 , pp. 363-368
    • Michelson, D.1    Fava, M.2    Amsterdam, J.3
  • 59
    • 0036738152 scopus 로고    scopus 로고
    • Discontinuation symptoms: Comparison of brief interruption in fluoxetine and paroxetine treatment
    • Judge R, Parry MG, Quail D, et al: Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment. Int Clin Psychopharmacol 2002; 17:217-225
    • (2002) Int Clin Psychopharmacol , vol.17 , pp. 217-225
    • Judge, R.1    Parry, M.G.2    Quail, D.3
  • 60
    • 27544459825 scopus 로고    scopus 로고
    • Randomized trial of sertraline versus venlafaxine XR in major depression: Efficacy and discontinuation symptoms
    • Sir A, D'Souza RF, Uguz S, et al: Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms. J Clin Psychiatry 2005; 66:1312-1320
    • (2005) J Clin Psychiatry , vol.66 , pp. 1312-1320
    • Sir, A.1    D'Souza, R.F.2    Uguz, S.3
  • 61
    • 0033764960 scopus 로고    scopus 로고
    • Abrupt and brief discontinuation of antidepressant treatment: Effects on cognitive function and psychomotor performance
    • Hindmarch I, Kimber S, Cockle SM: Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance. Int Clin Psychopharmacol 2000; 15:305-318
    • (2000) Int Clin Psychopharmacol , vol.15 , pp. 305-318
    • Hindmarch, I.1    Kimber, S.2    Cockle, S.M.3
  • 62
    • 33646762803 scopus 로고    scopus 로고
    • Antidepressant discontinuation syndrome: Consensus panel recommendations for clinical management and additional research
    • Schatzberg AF, Blier P, Delgado PL, et al: Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research. J Clin Psychiatry 2006; 67(suppl 4):27-30
    • (2006) J Clin Psychiatry , vol.67 , Issue.SUPPL. 4 , pp. 27-30
    • Schatzberg, A.F.1    Blier, P.2    Delgado, P.L.3
  • 63
    • 0030795390 scopus 로고    scopus 로고
    • Discontinuation symptoms after treatment with serotonin-reuptake inhibitors: A literature review
    • Zajecka J, Tracy KA, Mitchell S: Discontinuation symptoms after treatment with serotonin-reuptake inhibitors: a literature review. J Clin Psychiatry 1997; 58:291-297
    • (1997) J Clin Psychiatry , vol.58 , pp. 291-297
    • Zajecka, J.1    Tracy, K.A.2    Mitchell, S.3
  • 65
    • 33845989668 scopus 로고    scopus 로고
    • Antidepressant Discontinuation Syndrome: Current Perspectives and Consensus Recommendations for Management
    • Antidepressant Discontinuation Syndrome: Current Perspectives and Consensus Recommendations for Management. J Clin Psychiatry 2006; 67(suppl 4)
    • (2006) J Clin Psychiatry , vol.67 , Issue.SUPPL. 4
  • 66
    • 0038521163 scopus 로고    scopus 로고
    • Placental passage of antidepressant medications
    • Hendrick V, Stowe ZN, Altshuler LL, et al: Placental passage of antidepressant medications. Am J Psychiatry 2003; 160:993-996
    • (2003) Am J Psychiatry , vol.160 , pp. 993-996
    • Hendrick, V.1    Stowe, Z.N.2    Altshuler, L.L.3
  • 67
    • 0141843501 scopus 로고    scopus 로고
    • Assessment and treatment of depression during pregnancy: An update
    • Nonacs R, Cohen LS: Assessment and treatment of depression during pregnancy: an update. Psychiatr Clin North Am 2003; 26:547-562
    • (2003) Psychiatr Clin North Am , vol.26 , pp. 547-562
    • Nonacs, R.1    Cohen, L.S.2
  • 68
    • 0032564904 scopus 로고    scopus 로고
    • Pregnancy outcome following maternal use of the new selective serotonin-reuptake inhibitors: A prospective, controlled multicenter study
    • Kulin NA, Pastuszak A, Sage SR, et al: Pregnancy outcome following maternal use of the new selective serotonin-reuptake inhibitors: a prospective, controlled multicenter study. JAMA 1998; 279:609-610
    • (1998) JAMA , vol.279 , pp. 609-610
    • Kulin, N.A.1    Pastuszak, A.2    Sage, S.R.3
  • 69
    • 85030522912 scopus 로고    scopus 로고
    • EPIP083 (Preliminary Report) Epidemiology Study: Preliminary Report on Bupropion in Pregnancy and the Occurrence of Cardiovascular and Major Congenital Malformations, 2005; accessed December 15, 2005, at http://ctr.gsk.co.uk/ summary/bupropion/studylist.asp
    • EPIP083 (Preliminary Report) Epidemiology Study: Preliminary Report on Bupropion in Pregnancy and the Occurrence of Cardiovascular and Major Congenital Malformations, 2005; accessed December 15, 2005, at http://ctr.gsk.co.uk/ summary/bupropion/studylist.asp
  • 71
    • 0029795224 scopus 로고    scopus 로고
    • Birth outcomes in pregnant women taking fluoxetine
    • Chambers CD, Johnson KA, Dick LM, et al: Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335:1010-1015
    • (1996) N Engl J Med , vol.335 , pp. 1010-1015
    • Chambers, C.D.1    Johnson, K.A.2    Dick, L.M.3
  • 72
    • 17644411089 scopus 로고    scopus 로고
    • Antidepressant use during pregnancy and the rates of spontaneous abortions: A metaanalysis
    • Hemels ME, Einarson A, Koren G, et al: Antidepressant use during pregnancy and the rates of spontaneous abortions: a metaanalysis. Ann Pharmacother 2005; 39:803-809
    • (2005) Ann Pharmacother , vol.39 , pp. 803-809
    • Hemels, M.E.1    Einarson, A.2    Koren, G.3
  • 73
    • 0033951163 scopus 로고    scopus 로고
    • Safety of fluoxetine during the first trimester of pregnancy: A metaanalytical review of epidemiological studies
    • Addis A, Koren G: Safety of fluoxetine during the first trimester of pregnancy: a metaanalytical review of epidemiological studies. Psychol Med 2000; 30:89-94
    • (2000) Psychol Med , vol.30 , pp. 89-94
    • Addis, A.1    Koren, G.2
  • 74
    • 0033530293 scopus 로고    scopus 로고
    • Pharmacologic treatment of depression during pregnancy
    • Wisner KL, Gelenberg AJ, Leonard H, et al: Pharmacologic treatment of depression during pregnancy. JAMA 1999; 282:1264-1269
    • (1999) JAMA , vol.282 , pp. 1264-1269
    • Wisner, K.L.1    Gelenberg, A.J.2    Leonard, H.3
  • 75
    • 11144358525 scopus 로고    scopus 로고
    • Neonate characteristics after maternal use of antidepressants in late pregnancy
    • Källén B: Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004; 158:312-316
    • (2004) Arch Pediatr Adolesc Med , vol.158 , pp. 312-316
    • Källén, B.1
  • 77
    • 1842866929 scopus 로고    scopus 로고
    • Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure
    • Oberlander TF, Misri S, Fitzgerald CE, et al: Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65:230-237
    • (2004) J Clin Psychiatry , vol.65 , pp. 230-237
    • Oberlander, T.F.1    Misri, S.2    Fitzgerald, C.E.3
  • 78
    • 28444474891 scopus 로고    scopus 로고
    • Citalopram use in pregnancy: Prospective comparative evaluation of pregnancy and fetal outcome
    • Sivojelezova A, Shuhaiber S, Sarkissian L, et al: Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. Am J Obstet Gynecol 2005; 193:2004-2009
    • (2005) Am J Obstet Gynecol , vol.193 , pp. 2004-2009
    • Sivojelezova, A.1    Shuhaiber, S.2    Sarkissian, L.3
  • 79
    • 13444252680 scopus 로고    scopus 로고
    • Selective serotonin-reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: A database analysis
    • Sanz EJ, De-las-Cuevas C, Kiuru A, et al: Selective serotonin-reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005; 365(9458):482-487
    • (2005) Lancet , vol.365 , Issue.9458 , pp. 482-487
    • Sanz, E.J.1    De-las-Cuevas, C.2    Kiuru, A.3
  • 80
    • 32244441984 scopus 로고    scopus 로고
    • Neonatal abstinence syndrome after in-utero exposure to selective serotonin-reuptake inhibitors in term infants
    • Levinson-Castiel R, Merlob P, Linder N, et al: Neonatal abstinence syndrome after in-utero exposure to selective serotonin-reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006; 160:173-176
    • (2006) Arch Pediatr Adolesc Med , vol.160 , pp. 173-176
    • Levinson-Castiel, R.1    Merlob, P.2    Linder, N.3
  • 81
    • 32144436098 scopus 로고    scopus 로고
    • Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn
    • Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al: Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006; 354:579-587
    • (2006) N Engl J Med , vol.354 , pp. 579-587
    • Chambers, C.D.1    Hernandez-Diaz, S.2    Van Marter, L.J.3
  • 82
    • 0037399190 scopus 로고    scopus 로고
    • Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy
    • Casper RC, Fleisher BE, Lee-Ancajas JC, et al: Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003; 142:402-408
    • (2003) J Pediatr , vol.142 , pp. 402-408
    • Casper, R.C.1    Fleisher, B.E.2    Lee-Ancajas, J.C.3
  • 83
    • 0031022182 scopus 로고    scopus 로고
    • Neurodevelopment of children exposed in-utero to antidepressant drugs
    • Nulman I, Rovet J, Stewart DE, et al: Neurodevelopment of children exposed in-utero to antidepressant drugs. N Engl J Med 1997; 336:258-262
    • (1997) N Engl J Med , vol.336 , pp. 258-262
    • Nulman, I.1    Rovet, J.2    Stewart, D.E.3
  • 84
    • 85047697473 scopus 로고    scopus 로고
    • Internalizing behaviors in 4-year-old children exposed in-utero to psychotropic medications
    • Misri S, Reebye P, Kendrick K, et al: Internalizing behaviors in 4-year-old children exposed in-utero to psychotropic medications. Am J Psychiatry 2006; 163:1026-1032
    • (2006) Am J Psychiatry , vol.163 , pp. 1026-1032
    • Misri, S.1    Reebye, P.2    Kendrick, K.3
  • 85
    • 2942527162 scopus 로고    scopus 로고
    • Pooled analysis of anti-depressant levels in lactating mothers, breast milk, and nursing infants
    • Weissman AM, Levy BT, Hartz AJ, et al: Pooled analysis of anti-depressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 2004; 161:1066-1078
    • (2004) Am J Psychiatry , vol.161 , pp. 1066-1078
    • Weissman, A.M.1    Levy, B.T.2    Hartz, A.J.3
  • 86
    • 4444374093 scopus 로고    scopus 로고
    • A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate
    • Rampono J, Proud S, Hackett LP, et al: A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. Int J Neuropsychopharmacol 2004; 7:329-334
    • (2004) Int J Neuropsychopharmacol , vol.7 , pp. 329-334
    • Rampono, J.1    Proud, S.2    Hackett, L.P.3
  • 87
    • 5444248599 scopus 로고    scopus 로고
    • Breastfeeding during maternal antidepressant treatment with serotonin-reuptake inhibitors: Infant exposure, clinical symptoms, and cytochrome P450 genotypes
    • Berle JO, Steen VM, Aamo TO, et al: Breastfeeding during maternal antidepressant treatment with serotonin-reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome P450 genotypes. J Clin Psychiatry 2004; 65:1228-1234
    • (2004) J Clin Psychiatry , vol.65 , pp. 1228-1234
    • Berle, J.O.1    Steen, V.M.2    Aamo, T.O.3
  • 88
    • 0742269637 scopus 로고    scopus 로고
    • Frequency of infant adverse events that are associated with citalopram use during breast-feeding
    • Lee A, Woo J, Ito S: Frequency of infant adverse events that are associated with citalopram use during breast-feeding. Am J Obstet Gynecol 2004; 190:218-221
    • (2004) Am J Obstet Gynecol , vol.190 , pp. 218-221
    • Lee, A.1    Woo, J.2    Ito, S.3
  • 89
    • 1542267722 scopus 로고    scopus 로고
    • Paroxetine during breast-feeding: Infant weight gain and maternal adherence to counsel
    • Merlob P, Stahl B, Sulkes J: Paroxetine during breast-feeding: infant weight gain and maternal adherence to counsel. Eur J Pediatr 2004; 163:135-139
    • (2004) Eur J Pediatr , vol.163 , pp. 135-139
    • Merlob, P.1    Stahl, B.2    Sulkes, J.3
  • 90
    • 1642577953 scopus 로고    scopus 로고
    • Treatment of depression in women: A summary of the expert consensus guidelines
    • Altshuler LL, Cohen LS, Moline ML, et al: Treatment of depression in women: a summary of the expert consensus guidelines. J Psychiatr Pract 2001; 7:185-208
    • (2001) J Psychiatr Pract , vol.7 , pp. 185-208
    • Altshuler, L.L.1    Cohen, L.S.2    Moline, M.L.3
  • 91
    • 0036787468 scopus 로고    scopus 로고
    • Management of major depression during pregnancy
    • Hendrick V, Altshuler L: Management of major depression during pregnancy. Am J Psychiatry 2002; 159:1667-1673
    • (2002) Am J Psychiatry , vol.159 , pp. 1667-1673
    • Hendrick, V.1    Altshuler, L.2
  • 92
    • 12344284587 scopus 로고    scopus 로고
    • The use of selective serotonin-reuptake inhibitors during pregnancy and breast-feeding: A review and clinical aspects
    • Hallberg P, Sjöblom V: The use of selective serotonin-reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects. J Clin Psychopharmacol 2005; 25:59-73
    • (2005) J Clin Psychopharmacol , vol.25 , pp. 59-73
    • Hallberg, P.1    Sjöblom, V.2
  • 93
    • 7644238337 scopus 로고    scopus 로고
    • Relapse of depression during pregnancy following antidepressant discontinuation: A preliminary prospective study
    • Cohen LS, Nonacs RM, Bailey JW, et al: Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study. Archives of Women's Mental Health 2004; 7:217-221
    • (2004) Archives of Women's Mental Health , vol.7 , pp. 217-221
    • Cohen, L.S.1    Nonacs, R.M.2    Bailey, J.W.3
  • 94
    • 16244377094 scopus 로고    scopus 로고
    • Implications of antenatal depression and anxiety for obstetric outcome
    • Andersson L, Sundstrom-Poromaa I, Wulff M, et al: Implications of antenatal depression and anxiety for obstetric outcome. Obstet Gynecol 2004; 104:467-476
    • (2004) Obstet Gynecol , vol.104 , pp. 467-476
    • Andersson, L.1    Sundstrom-Poromaa, I.2    Wulff, M.3
  • 95
    • 0010551097 scopus 로고    scopus 로고
    • Depressive symptoms in parents of children under three: Sociodemographic predictors, current correlates, and associated parenting behaviors
    • Edited by Halfon N, Schuster M, Taaffe-Young K. New York, Cambridge University Press;
    • Lyons-Ruth K, Wolfe R, Lyubchik A, et al: Depressive symptoms in parents of children under three: sociodemographic predictors, current correlates, and associated parenting behaviors, in Child-Rearing in America: Challenges Facing Parents With Young Children. Edited by Halfon N, Schuster M, Taaffe-Young K. New York, Cambridge University Press; 2002, pp 217-262
    • (2002) Child-Rearing in America: Challenges Facing Parents With Young Children , pp. 217-262
    • Lyons-Ruth, K.1    Wolfe, R.2    Lyubchik, A.3
  • 96
    • 0026568290 scopus 로고
    • The impact of postnatal depression on infant development
    • Murray L: The impact of postnatal depression on infant development. J Child Psychol Psychiatry 1992; 33:543-561
    • (1992) J Child Psychol Psychiatry , vol.33 , pp. 543-561
    • Murray, L.1
  • 97
    • 0035026947 scopus 로고    scopus 로고
    • Is there an association between selective serotonin-reuptake inhibitors and risk of abnormal bleeding? results from a cohort study based on prescription event monitoring in England
    • Layton D, Clark DW, Pearce GL, et al: Is there an association between selective serotonin-reuptake inhibitors and risk of abnormal bleeding? results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol 2001; 57:167-176
    • (2001) Eur J Clin Pharmacol , vol.57 , pp. 167-176
    • Layton, D.1    Clark, D.W.2    Pearce, G.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.